# Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause

> **NCT00366093** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 410 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00366093
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00366093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00366093, "Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00366093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*